Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing
Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Showing 20 of 0 results